Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

07-01-2021 | ORIGINAL PAPER | Uitgave 4/2021

Mindfulness 4/2021

Usage Patterns of the Calm Meditation App Among People with Cardiovascular Disease

Tijdschrift:
Mindfulness > Uitgave 4/2021
Auteurs:
Christina M. Luberto, Jen Huberty, Megan Puzia, Ana-Maria Vranceanu
Belangrijke opmerkingen

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abstract

Objectives

Cardiovascular disease (CVD) is the leading cause of death worldwide and is highly comorbid with emotional disorders. Mindfulness meditation can improve health outcomes in people with CVD. Calm is the most popular smartphone meditation app, but the usage patterns among people with CVD have not been explored.

Methods

We conducted a secondary analysis of a cross-sectional survey study among N = 1512 Calm subscribers with CVD to explore user characteristics, usage patterns, and health changes, and compare the results among those with and without co-occurring anxiety or depression.

Results

Users were primarily white (83%), female (74%), and had relatively high income (45% with > $100,000/year). Most (67%) used Calm at least 5 ×/week and started using Calm to help with sleep (69%) and stress (67%). More users with anxiety or depression, compared to CVD-only, started Calm to help with stress (71% vs. 64%) and anxiety or depression (77% vs. 37%), and used components incorporating sounds and physical movements more often (all p’s < 0.05). Most participants reported changes in sleep, stress, and physical and mental health (60–79%), though changes were more prevalent among those with anxiety or depression (p’s < 0.001). More frequent Calm use was associated with greater health changes (p’s < 0.05).

Conclusions

Calm users with CVD use the app regularly to help with health promotion and, particularly those with anxiety or depression, perceive health changes from their Calm use. Randomized controlled trials are needed to establish the efficacy and optimal dose of Calm use for people with CVD.

Log in om toegang te krijgen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Psychologie Totaal

Met BSL Psychologie Totaal blijf je als professional steeds op de hoogte van de nieuwste ontwikkelingen binnen jouw vak. Met het online abonnement heb je toegang tot een groot aantal boeken, protocollen, vaktijdschriften en e-learnings op het gebied van psychologie en psychiatrie. Zo kun je op je gemak en wanneer het jou het beste uitkomt verdiepen in jouw vakgebied.

Literatuur
Over dit artikel

Andere artikelen Uitgave 4/2021

Mindfulness 4/2021 Naar de uitgave

MINDFULNESS IN PRACTICE

Making Daily Determinations